RAAJMEDI.BO · BSE
RAAJ MEDISAFE INDIA LTD.
₹95
-2.06% (-₹2)
Prev. close
₹97
Volume
201
As of
24 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About RAAJ MEDISAFE INDIA LTD.
Raaj Medisafe India Limited manufactures and sells disposable hygiene products, HDPE containers, PP closures and plastic liners for packaging of goods, and aluminum crown caps in India. The company operates through two segments, Plastic and Hygiene. It offers caps and plugs, plastic liners, and aluminum caps. The company also offers sanitary napkins, maternity pads, baby diapers and panty liners. In addition, it offers aluminium and VCI bags, plastic rolls, food grade poly bags and sheet, and DMF certified poly bags and sheets. The company was formerly known as Manoj Surgical Industries Limited. Raaj Medisafe India Limited was incorporated in 1985 and is based in Ujjain, India.
Details
Sector
Consumer Cyclical
Industry
Packaging & Containers
CEO
Mr. Arpit Bangur
Headquarters
Ujjain
Employees
214
Website
raajmedisafeindia.comExchange
View on BSE ↗Key stats
Market cap
₹156.68 Cr
P/E ratio (TTM)
79.8
EPS (TTM)
₹1.19
Beta (1Y · daily vs NIFTY 50)
0.58
Beta (5Y · monthly vs NIFTY 50)
0.80
Shares float
64.37 L
EPS · quarter ended Jun 2026
₹1.20
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹31.81 Cr | ₹34.69 Cr | ₹38.62 Cr | ₹43.25 Cr | ₹62.42 Cr | ₹80.01 Cr | |
| EBITDA | ₹4.09 Cr | ₹5.11 Cr | ₹5.58 Cr | ₹6.58 Cr | ₹8.72 Cr | ₹12.01 Cr |
| ₹2.30 Cr | ₹3.01 Cr | ₹3.33 Cr | ₹3.33 Cr | ₹6.13 Cr | ₹1.81 Cr | |
| Diluted EPS | ₹2.07 | ₹2.82 | ₹3.06 | ₹3.07 | ₹4.6 | ₹1.1 |
Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹25.77 Cr | ₹41.29 Cr | ₹68.99 Cr | ₹121.35 Cr | |
| — | — | ₹15.61 Cr | ₹25.93 Cr | ₹34.57 Cr | ₹64.67 Cr | |
| Stockholders' equity | — | — | ₹7.49 Cr | ₹10.84 Cr | ₹26.92 Cr | ₹46.74 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹17.40 L | ₹4.27 Cr | ₹-8.68 L | ₹3.67 Cr | |
| Investing cash flow | — | — | ₹-1.67 Cr | ₹-13.00 Cr | ₹-16.42 Cr | ₹-34.95 Cr |
| — | — | ₹1.49 Cr | ₹8.74 Cr | ₹16.52 Cr | ₹44.23 Cr | |
| Capital expenditure | — | — | ₹-1.73 Cr | ₹-11.64 Cr | ₹-14.71 Cr | ₹-33.50 Cr |
| End cash position | — | — | ₹2.65 L | ₹4.42 L | ₹6.49 L | ₹13.01 Cr |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Consumer Cyclical
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Titan Company Limited | ₹4.33 L Cr | ₹4,832.5 | 75.3 | 27.57 | 32.3% | 1.95 | +44.8% | +41.4% |
| Maruti Suzuki India Limited | ₹3.85 L Cr | ₹11,990 | 26.8 | 3.59 | 13.7% | 0.00 | +20.1% | -26.2% |
| Mahindra & Mahindra Limited | ₹3.64 L Cr | ₹2,982.7 | 18.5 | 3.91 | 18.4% | 1.44 | +24.1% | -16.6% |
| ETERNAL LIMITED | ₹3.15 L Cr | ₹335.5 | 761.4 | 10.18 | 1.2% | 0.15 | +168.6% | -0.1% |
| Bajaj Auto Limited | ₹3.13 L Cr | ₹11,208 | 27.1 | 8.07 | 27.7% | 0.58 | +22.6% | +26.8% |
| Eicher Motors Limited | ₹2.04 L Cr | ₹7,338.5 | 35.4 | 8.13 | 22.0% | 0.02 | +23.9% | +4.7% |
| TVS Motor Company Limited | ₹1.97 L Cr | ₹4,091 | 57.4 | 20.55 | 31.6% | 3.43 | +29.2% | +18.5% |
| Samvardhana Motherson International Limited | ₹1.73 L Cr | ₹162.5 | 39.5 | 4.22 | 9.4% | 0.47 | +11.1% | +50.5% |
| Hyundai Motor India Limited | ₹1.70 L Cr | ₹2,060.6 | 34.5 | 8.50 | 27.1% | 0.05 | +2.1% | -25.2% |
| Tata Motors Limited | ₹1.61 L Cr | ₹437.15 | 37.5 | 12.64 | 23.8% | 0.44 | +44.3% | — |
| Trent Limited | ₹1.48 L Cr | ₹2,700 | 82.0 | 21.18 | 24.6% | 0.37 | +17.6% | -44.9% |
| RAAJ MEDISAFE INDIA LTD. | ₹159.98 Cr | ₹97 | 81.5 | 3.42 | 3.9% | 1.38 | +28.2% | — |
Ranked by market cap within Consumer Cyclical, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 24
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Raaj Medisafe India hits 52-week high on securing LoA worth Rs 17.02 crore
Raaj Medisafe India's stock reached a 52-week high after securing a Letter of Award worth Rs 17.02 crore. The order from Madhya Pradesh Public Health Services Corporation is for the supply of baby diapers to government hospitals. The company will execute the order within 18 months.